Abciximab in Wake-up Stroke

Terminated

Phase 3 Results N/A

Summary of Purpose

The purpose of the prospective, randomized, double blind, placebo-controlled multicenter pilot study is to evaluate the effectiveness of abciximab on rescuing the hypoperfused brain tissue, as assessed by MRI, and the relative safety of abciximab in patients with wake-up stroke. Trial Stopped: Higher hemorrhage rates of Abciximab in ABESST II trial

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2007.

1 Mar 2005 9 Sep 2005 Unavailable 1 May 2005 1 May 2007 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available